Type 2 Diabetes in Youth: How Serious Is It?

While three decades ago it was rare for a child or teen to be diagnosed with type 2 diabetes, today, the American Medical Association (AMA) estimates that there are about 3,700 new cases a year among youth in the United States. While the majority of new diabetes diagnoses in children are still type 1 – about 13,000 a year – the escalating numbers of type

Read more

Study Shows Therapeutic Footwear Can Help Prevent Foot Ulcers

Diabetic peripheral neuropathy is caused by reduced blood flow to the extremities. High blood glucose levels damage blood vessels and affect the blood flow. Those with type 2 diabetes are at a higher risk for foot ulcers and lower limb amputations. They also account for 60 percent of the limb amputations, according to the American Diabetes Association. A new study from the Milwaukee-based company Dr.

Read more

Keeping Your Feet Fit for Travel

You’re at your destination and ready to see what there is to see. The real question is this: Are you ready to walk? For people with diabetes, this can be a complicated question. Those who’ve dealt with the disease for many years may have some sort of problem with their feet. It doesn’t have to be major–possibly some mild nerve damage or extra calluses–but such

Read more

Skin Cream Could Treat Peripheral Neuropathy

One of the most debilitating risks of diabetes is peripheral neuropathy, which can impact millions of people each year and often leads to amputation. It’s difficult to treat, but researchers at Boston Children’s Hospital are working to develop a skin cream that may relieve it. The cream, which has been tested on mice in two trials, is designed to enhance GDNF (Glial cell-derived neurotrophic factor),

Read more

Enzyme Discovery Could Predict Diabetic Neuropathy

Physicians may be able to predict if diabetic patients will develop peripheral neuropathy, thanks to results of new research. According to the research, which appeared in the American Diabetes Association journal Diabetes Care, the levels of an enzyme known as neuron-specific enolase are elevated in people with diabetes, even more so in those suffering from diabetic neuropathy. The results are exciting for researchers, because it

Read more

FDA Approves New Neuropathy Pain Drug

The US Food and Drug Administration has approved US sales of NUCYNTA® ER (tapentadol), a twice-daily extended-release oral analgesic for the treatment of pain from diabetic peripheral neuropathy. The drug, produced by New Jersey-based Janssen Pharmaceuticals, Inc., provides around-the-clock management for moderate to severe chronic neuropathic pain. Janssen says that it is currently the only opioid on the US market that has been approved for

Read more

Unnecessary, Expensive Tests Performed for Diabetic Neuropathy

One quarter of patients with diabetic neuropathy undergo unnecessary, expensive tests, according to a study by Brian Callaghan, MD, of the University of Michigan Medical School. When Dr. Callaghan and his team looked at 1996-2007 Medicare claims of patients diagnosed with peripheral neuropathy, they found that the most common test performed was an MRI of the brain or spine. There were far fewer instances of

Read more